<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02515721</url>
  </required_header>
  <id_info>
    <org_study_id>2015SDU-QILU-G06</org_study_id>
    <nct_id>NCT02515721</nct_id>
  </id_info>
  <brief_title>PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma</brief_title>
  <acronym>PCLE</acronym>
  <official_title>Probe-based Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia,Intraepithelial Neoplasia,and Carcinoma:A Multicenter,Randomized,Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early detection of gastric intestinal metaplasia (GIM) intraepithelial neoplasia (IN), and
      gastric cancer are essential to improve patients' outcomes. This study aims to compare the
      diagnostic yield of GIM, IN and early gastric cancer (EGC) by iScan combined probe-based
      confocal laser endomicroscopy (pCLE) and iScan alone.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the diagnostic yield of intestinal metaplasia, intraepithelial neoplasia, and gastric cancer</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the biopsy number needed for diagnosis</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">242</enrollment>
  <condition>Diagnostic Yield of Gastric Neoplasia</condition>
  <arm_group>
    <arm_group_label>pCLE-TB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive white-light endoscopic imaging, followed by probe-based Confocal Laser Endomicroscopy scanning on suspected lesions and 5 standardized locations. Then targeted Biopsies will be performed on locations with intestinal metaplasia, intraepithelial neoplasia, and carcinoma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Virtual Chromoendoscopy -SB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive virtual chromoendoscopy using iScan. Standard biopsies will be performed on all suspected lesions and standardized loctaions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pCLE-TB</intervention_name>
    <description>Patients will receive white-light endoscopic imaging, followed by probe-based Confocal Laser Endomicroscopy scanning on suspected lesions and 5 standardized locations. Then targeted Biopsies will be performed on locations with intestinal metaplasia, intraepithelial neoplasia, and carcinoma.</description>
    <arm_group_label>pCLE-TB</arm_group_label>
    <other_name>probe-based confocal laser endomicroscopy with targeted biopsies</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>virtual chromoendoscopy-TB</intervention_name>
    <description>Patients will receive virtual chromoendoscopy using iScan. Standard biopsies will be performed on all suspected lesions and standardized loctaions.</description>
    <arm_group_label>Virtual Chromoendoscopy -SB</arm_group_label>
    <other_name>virtual chromoendoscopy with targeted biopsies</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged between 18 and 80;

          -  patients with previous pathologic diagnosis of atrophic gastritis, gastric intestinal
             metaplasia, and low-grade intraepithelial neoplasia;

          -  agree to give written informed consent.

        Exclusion Criteria:

          -  Patients with gastrectomy, acute GI bleeding, and known gastric neoplasia;

          -  Patients under conditions unsuitable for performing CLE including coagulopathy
             (prothrombin time &lt;50% of control, partial thromboplastin time &gt;50 s), impaired renal
             function (creatinine level &gt;1.2 mg/dL), pregnancy or breastfeeding, and known allergy
             to fluorescein sodium;

          -  Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Li Yanqing, PhD, MD</last_name>
    <phone>053182169385</phone>
    <email>liyanqing@sdu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li Zhen, PhD, MD</last_name>
    <phone>18560086106</phone>
    <email>lizhenh@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Endoscopic unit of Qilu Hospital Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Yanqing, PhD, MD</last_name>
      <phone>053182169385</phone>
      <email>liyanqing@sdu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Li Zhen, PhD, MD</last_name>
      <phone>18560086106</phone>
      <email>lizhenh@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zuo Xiuli, PhD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2015</study_first_posted>
  <last_update_submitted>August 3, 2015</last_update_submitted>
  <last_update_submitted_qc>August 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>Chief of the department of Gastroenterology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Metaplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

